Bis(2-ethylhexyl) maleate
- Product NameBis(2-ethylhexyl) maleate
- CAS142-16-5
- CBNumberCB6393335
- MFC20H36O4
- MW340.5
- EINECS205-524-5
- MDL NumberMFCD00027250
- MOL File142-16-5.mol
- MSDS FileSDS
Chemical Properties
| Melting point | -50°C |
| Boiling point | 208-209°C 10mm |
| Density | 0.944 g/mL at 25 °C(lit.) |
| Pour Point | -50 |
| vapor pressure | 0Pa at 20℃ |
| refractive index | n |
| Flash point | >230 °F |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Chloroform (Sparingly), Ethyl Acetate(Slightly),Methanol (Slightly) |
| form | Liquid |
| color | Colourless |
| Viscosity | 16cp (25C) |
| Water Solubility | 18μg/L at 20℃ |
| InChIKey | ROPXFXOUUANXRR-YPKPFQOOSA-N |
| LogP | 7.24 at 25℃ |
| CAS DataBase Reference | 142-16-5(CAS DataBase Reference) |
| Indirect Additives used in Food Contact Substances | DI(2-ETHYLHEXYL) MALEATE |
| FDA 21 CFR | 175.105; 176.180 |
Safety
| Symbol(GHS) |
 
|
|||||||||
| Signal word | Warning | |||||||||
| Hazard statements | H373-H410 | |||||||||
| Precautionary statements | P260-P273-P314-P391-P501 | |||||||||
| Hazard Codes | Xi,N,Xn | |||||||||
| Risk Statements | 36/38-51/53-48/22 | |||||||||
| Safety Statements | 26-36-61 | |||||||||
| WGK Germany | 1 | |||||||||
| RTECS | ON0160000 | |||||||||
| HS Code | 29171900 | |||||||||
| Hazardous Substances Data | 142-16-5(Hazardous Substances Data) | |||||||||
| Toxicity | A hallucinogenic (psychedelic) agent. It may catalyze the onset of emotional problems or psychosis in predisposed individuals. Although the mechanism of action for hallucinogens is not understood, DOM is believed to act by being an agonist at serotonin 5-HT2 receptors. It causes hyperreflexia, restlessness, and perceptual alterations in illusions, including changes in touch, taste, and odor, and the thinking process is substantially altered. At high doses, hallucinations and loss of contact with reality result. The duration of action may be 16-24 h. Its LD50 is in mice 36 mg/kg, i.v., in rats 32.5 mg/ kg, i.p., in dogs 7.2 mg/kg, i.v., and in monkeys 8 mg/kg, i.v. | |||||||||
| NFPA 704: |
|
